KORU Medical Systems (NASDAQ:KRMD) Given New $6.00 Price Target at Craig Hallum

KORU Medical Systems (NASDAQ:KRMD) had its price objective raised by investment analysts at Craig Hallum from $5.00 to $6.00 in a research report issued on Friday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Craig Hallum’s price target would indicate a potential upside of 44.54% from the company’s previous close.

KRMD has been the topic of several other research reports. Lake Street Capital raised their price target on shares of KORU Medical Systems from $4.00 to $5.00 and gave the company a “buy” rating in a research report on Tuesday. Canaccord Genuity Group lifted their price target on KORU Medical Systems from $3.00 to $4.00 and gave the company a “buy” rating in a research note on Thursday, November 14th. Finally, Piper Sandler increased their price target on KORU Medical Systems from $3.00 to $3.50 and gave the stock an “overweight” rating in a research report on Thursday, November 14th. Four equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. According to MarketBeat, KORU Medical Systems presently has a consensus rating of “Buy” and a consensus target price of $4.50.

KORU Medical Systems Stock Performance

Shares of KRMD stock traded up $0.15 on Friday, hitting $4.15. The company had a trading volume of 141,452 shares, compared to its average volume of 103,131. KORU Medical Systems has a twelve month low of $1.98 and a twelve month high of $4.60. The firm has a market cap of $190.27 million, a P/E ratio of -16.68 and a beta of 0.45. The company has a 50-day moving average price of $3.80 and a 200-day moving average price of $2.96. The company has a quick ratio of 2.37, a current ratio of 2.99 and a debt-to-equity ratio of 0.01.

Institutional Investors Weigh In On KORU Medical Systems

Several institutional investors have recently bought and sold shares of KRMD. Point72 Asia Singapore Pte. Ltd. purchased a new position in shares of KORU Medical Systems in the second quarter valued at approximately $107,000. Meros Investment Management LP raised its stake in KORU Medical Systems by 20.7% in the 2nd quarter. Meros Investment Management LP now owns 804,380 shares of the company’s stock valued at $2,132,000 after purchasing an additional 137,918 shares during the last quarter. Connor Clark & Lunn Investment Management Ltd. lifted its holdings in KORU Medical Systems by 77.7% in the 3rd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 61,412 shares of the company’s stock valued at $168,000 after purchasing an additional 26,860 shares in the last quarter. XTX Topco Ltd acquired a new stake in KORU Medical Systems during the 3rd quarter worth $34,000. Finally, Geode Capital Management LLC boosted its stake in KORU Medical Systems by 6.5% during the 3rd quarter. Geode Capital Management LLC now owns 462,128 shares of the company’s stock worth $1,262,000 after purchasing an additional 28,323 shares during the last quarter. 58.60% of the stock is currently owned by institutional investors and hedge funds.

About KORU Medical Systems

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.